Tr1X
A Senior Scientist at Tr1X develops and optimizes lipid nanoparticle (LNP) formulations and processes for mRNA delivery, supporting the company's in vivo CAR-Treg platform. The role involves designing scalable manufacturing processes and contributing to IND-enabling documentation.
Tr1X is a clinical-stage biotechnology company engineering a novel class of regulatory T cell-based therapies to cure autoimmune and inflammatory diseases. Leveraging cutting-edge genetic engineering and deep immunology expertise, Tr1X develops allogeneic, off-the-shelf Tr1/Treg cell therapies designed to restore immune tolerance and reset the immune system. The company has four active clinical programs spanning Crohn's disease, multiple sclerosis, graft-versus-host disease prevention following stem cell transplant, and autoimmune uveitis.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tr1X.
11% above the average for this role
Scientist II, LNP
CRISPR Therapeutics
Scientist, LNP Process and Development
Flagship Pioneering, Inc.
Associate Scientist - LNP Formulation
Eli Lilly and Company
Head of mRNA Delivery
Kernal Biologics, Inc.
Director II, LNP Platform Technology
AbbVie
Senior Scientist, Discovery Sciences & Technologies
Gilead Sciences